Dislipidemias en niños y adolescentes: factores determinantes y recomendaciones para su diagnóstico y manejo.
DOI:
https://doi.org/10.14306/373Palabras clave:
Dislipidemias, Niño, Adolescente, Diagnóstico, TerapéuticaResumen
El presente artículo tiene como objetivoidentificar los factores y determinantes que inciden en la dislipidemia infantil y adolescente, así como las recomendaciones existentes sobre el diagnóstico, manejo y seguimiento clínico. Se realizó una revisión narrativa consultando en PubMed, Web of Science y SciELO de artículos publicados entre 2010-2017, en población infantil y adolescente, que incluyan descripción de la patología, programas, manejo y tratamiento. Se hallaron 193 artículos. Se seleccionaron 32 que cumplían los criterios de inclusión, distribuidos en 2 grupos: uno que contiene 19 estudios originales describiendo factores para la aparición de esta patología y otro que agrupa 13 estudios correspondientes a recomendaciones para su diagnóstico y manejo. Respecto a los determinantes de las dislipidemias, el sobrepeso y/u obesidad en niños se ha descrito como el principal factor desencadenante. Aunque se observan avances sobre los tratamientos recomendados y cierto consenso acerca de las fases del mismo, todavía no existen recomendaciones unificadas con respecto a su detección precoz. Algunos autores apoyan la realización del cribado en toda la población infantil, mientras otros únicamente lo consideran necesario en niños con riesgo elevado. El tratamiento de primera línea se basa en cambios dietéticos y de actividad física, relegando al farmacológico como última opción.
Citas
(1) Casavalle PL, Romano L, Pandolfo M, Rodriguez PN, Friedman SM. Prevalencia de dislipidemia y sus factores de riesgo en niños y adolescentes con sobrepeso y obesidad. Rev Esp Nutr Hum Diet. 2014;18(3):137-44.
(2) Alvarez F, Díaz JJ, Riaño I, Pérez D, Venta R, Málaga S. Factores de riesgo cardiovascular clásicos y emergentes en escolares asturianos. An Pediatr. 2011;74(6):388-95.
(3) Chahal N, Wong H, Manlhiot C, McCrindle BW. Education for lifestyle-based management of hyperlipidemia in children enhanced by a collaborative approach. J Clin Lipidol. 2014;8(2):187-93.
(4) Quadros TMB de, Gordia AP, Silva LR, Silva DAS, Mota J. Inquérito epidemiológico em escolares: determinantes e prevalência de fatores de risco cardiovascular. Cad Saude Publica. 2016;32(2):e00181514.
(5) Brogan K, Danford C, Yeh Y, Jen K-LC. Cardiovascular disease risk factors are elevated in urban minority children enrolled in head start. Child Obes. 2014;10(3):207-13.
(6) Peterson AL, McBride PE. A review of guidelines for dyslipidemia in children and adolescents. WMJ. 2012;111(6):274-281; quiz 282.
(7) Fernandes RA, Christofaro DGD, Casonatto J, Codogno JS, Rodrigues EQ, Cardoso ML, et al. Prevalência de dislipidemia em indivíduos fisicamente ativos durante a infância, adolescência e idade adulta. Arq Bras Cardiol. 2011;97(4):317-23.
(8) Barja S, Arnaiz P, Villarroel L, Domínguez A, Castillo O, Farías M, et al. Dislipidemias en escolares chilenos: prevalencia y factores asociados. Nutr Hosp. 2015;31(5):2079-87.
(9) Organización Mundial de la Salud. La salud de los jóvenes: un desafío para la sociedad. Madrid, España: OMS; 1986. (Serie de Informes Técnicos 731). Disponible en: http://whqlibdoc.who.int/trs/WHO_TRS_731_spa.pdf
(10) Organización Mundial de la Salud. El estado físico: uso e interpretación de la antropometría. Madrid, España: OMS; 1995. (Serie de Informes Técnicos 854). Disponible en: http://apps.who.int/iris/bitstream/10665/42132/1/WHO_TRS_854_spa.pdf
(11) NCEP Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3):495-501.
(12) Garcés C, de Oya M, Investigadores del estudio Cuatro Provincias. Factores de riesgo cardiovascular en la edad infantil. Resultados globales del estudio Cuatro Provincias. Rev Esp Cardiol. 2007;60(5):517-24.
(13) Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-256.
(14) Yoon JM. Dyslipidemia in children and adolescents: when and how to diagnose and treat? Pediatr Gastroenterol Hepatol Nutr. 2014;17(2):85-92.
(15) Montero CM. Importancia del estudio del perfil lipídico en niños obesos. Importance of studying the lipid profile in obese children. Rev Gastrohnup. 2010;12(2):81-3.
(16) Halpern A, Mancini MC, Magalhães MEC, Fisberg M, Radominski R, Bertolami MC, et al. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr. 2010;2:55.
(17) Arroyo FJ, Romero JA, López GN. Hiperlipemias. Protoc Diagn Ter Pediatr. 2011;1:104-16.
(18) Tafani R, Chiesa G, Caminati R, Gaspio N. Factores de riesgo y determinantes de la salud. Rev Salud Publica. 2013;17(3):53-68.
(19) Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation. 2001;104(23):2815-9.
(20) Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290(17):2271-6.
(21) Mahoney LT, Burns TL, Stanford W, Thompson BH, Witt JD, Rost CA, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996;27(2):277-84.
(22) Gidding SS, Rana JS, Prendergast C, McGill H, Carr JJ, Liu K, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age: The CARDIA Study. Circulation. 2016;133(2):139-46.
(23) Juonala M, Viikari JSA, Rönnemaa T, Marniemi J, Jula A, Loo B-M, et al. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2008;28(5):1012-7.
(24) Mata P, Alonso R, Ruiz A, Gonzalez-Juanatey JR, Badimón L, Díaz-Díaz JL, et al. Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso. Aten Primaria. 2015;47(1):56-65.
(25) Magalhães TCA, Vieira SA, Priore SE, Ribeiro AQ, Franceschini S do CC, Sant’ana LF da R. Associated factors with dyslipidemia in children 4 to 7 years old. Rev Nutr. 2015;28(1):17-28.
(26) Barja S, Cordero ML, Baeza C, Hodgson MI, Rama de Nutrición de Sociedad Chilena de Pediatría. Diagnóstico y tratamiento de las dislipidemias en niños y adolescentes: Recomendaciones de la Rama de Nutrición de la Sociedad Chilena de Pediatría. Rev Chil Pediatr. 2014;85(3):367-77.
(27) Fagherazzi S, Dias R da L, Bortolon F. Impacto do exercício físico isolado e combinado com dieta sobre os níveis séricos de HDL, LDL, colesterol total e triglicerídeos. Rev Bras Med Esporte. 2008;14(4):381-6.
(28) Nobre LN, Lamounier JA, Franceschini S do CC. Sociodemographic, anthropometric and dietary determinants of dyslipidemia in preschoolers. J Pediatr. 2013;89(5):462-9.
(29) Erol M, Bostan Gayret Ö, Hamilçıkan Ş, Can E, Yiğit ÖL. La deficiencia de vitamina D y la resistencia a la insulina como factores de riesgo de dislipidemia en niños obesos. Arch Argent Pediatr. 2017;115(2):133-9.
(30) Buitrago-Lopez A, van den Hooven EH, Rueda-Clausen CF, Serrano N, Ruiz AJ, Pereira MA, et al. Socioeconomic status is positively associated with measures of adiposity and insulin resistance, but inversely associated with dyslipidaemia in Colombian children. J Epidemiol Community Health. 2015;69(6):580-7.
(31) Valdés B, María J, Díaz P, Cecilia L, Alonso V, Carmen M del, et al. Duración de lactancia materna exclusiva, estado nutricional y dislipidemia en pacientes pediátricos. Rev Cubana Pediatr. 2015;87(2):156-66.
(32) Rodríguez L, Fernández-Britto JE, Sánchez D, Elena M, Ruiz V, Hernández H, et al. Sobrepeso y dislipidemias en adolescentes. Rev Cubana Pediatr. 2014;86(4):433-44.
(33) Stewart CP, Christian P, Wu LSF, LeClerq SC, Khatry SK, West KP. Prevalence and risk factors of elevated blood pressure, overweight, and dyslipidemia in adolescent and young adults in rural Nepal. Metab Syndr Relat Disord. 2013;11(5):319-28.
(34) Rosini N, Machado MJ, Webster IZ, Moura SAZO, Cavalcante L da S, da Silva EL. Simultaneous prediction of hyperglycemia and dyslipidemia in school children in Santa Catarina State, Brazil based on waist circumference measurement. Clin Biochem. 2013;46(18):1837-41.
(35) Gong C, Wu Q, Chen Z, Zhang D, Zhao Z, Peng Y. Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study. Lipids Health Dis. 2013;12:129.
(36) Ribas SA, Santana LC. Anthropometric indices: predictors of dyslipidemia in children and adolescents from north of Brazil. Nutr Hosp. 2012;27(4):1228-35.
(37) de Alcântara OD, Silva R de CR, Assis AMO, Pinto E de J. Factors associated with dyslipidemia in children and adolescents enrolled in public schools of Salvador, Bahia. Rev Bras Epidemiol. 2012;15(2):335-45.
(38) Hirschler V, Maccallini G, Aranda C, Molinari C, San Antonio de los Cobres Study Group. Dyslipidemia without obesity in indigenous Argentinean children living at high altitude. J Pediatr. 2012;161(4):646-651.e1.
(39) Hirschler V, Maccallini G, Aranda C, Molinari C, San Antonio de los Cobres Study Group. Lifestyle behaviors and dyslipidemia in Argentinean native versus urban children. Clin Biochem. 2012;45(15):1161-6.
(40) Tomerak RH, Galal NM, Abdelhady SH, Naem KA. Clinical scenario of primary dyslipidaemia in the paediatric age group; an Egyptian experience. J Pak Med Assoc. 2012;62(4):321-8.
(41) Vieira SC, Oliveira C, Galvão L, Medeiros PR, Arrais RF, Campos LF. Association between dyslipidemia and anthropometric indicators in adolescents. Nutr Hosp. 2011;26(2):304-10.
(42) Hirschler V, Molinari C, Maccallini G, Aranda C, Oestreicher K. Comparison of different anthropometric indices for identifying dyslipidemia in school children. Clin Biochem. 2011;44(8-9):659-64.
(43) Li Y, Wedick NM, Lai J, He Y, Hu X, Liu A, et al. Lack of dietary diversity and dyslipidaemia among stunted overweight children: the 2002 China National Nutrition and Health Survey. Public Health Nutr. 2011;14(5):896-903.
(44) Kaur S, Kapil U. Dyslipidemia amongst obese children in national capital territory (NCT) of Delhi. Indian J Pediatr. 2011;78(1):55-7.
(45) D’Adamo E, Guardamagna O, Chiarelli F, Bartuli A, Liccardo D, Ferrari F, et al. Atherogenic dyslipidemia and cardiovascular risk factors in obese children. Int J Endocrinol. 2015;2015:912047.
(46) Comité de Nutrición de la Sociedad Argentina de Pediatría. Consenso sobre manejo de las dislipidemias en pediatría. Arch Argent Pediatr. 2015;113(2):177-86.
(47) Loio M, Maia D de A. Rastreio de dislipidemias em crianças e adolescentes: a evidência que sustenta as recomendações. Rev Port Med Geral Fam. 2014;30(4):264-7.
(48) Guardamagna O, Cagliero P, Abello F. Management of inherited atherogenic dyslipidemias in children. Ther Apher Dial. 2013;17(2):150-61.
(49) Kennedy MJ, Jellerson KD, Snow MZ, Zacchetti ML. Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents. Paediatr Drugs. 2013;15(5):335-42.
(50) Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Directriz Brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20.
(51) Hardy OT, Wiecha J, Kim A, Salas C, Briceno R, Moody K, et al. Effects of a multicomponent wellness intervention on dyslipidemia among overweight adolescents. J Pediatr Endocrinol Metab. 2012;25(1-2):79-82.
(52) Cook S, Kavey REW. Dyslipidemia and pediatric obesity. Pediatr Clin North Am. 2011;58(6):1363-1373, ix.
(53) Machado L, Macías C, Mejías A, Méndez C, Merino G. Manejo integral de las dislipidemias en niños y adolescentes. Arch Venez Puer Ped. 2010;73(2):73-8.
(54) Direção-Geral da Saúde. Programa Nacional de Saúde infantil e juvenil. Lisboa, Portugal: Direção-Geral da Saúde; 2013. Disponible en: https://www.dgs.pt/documentos-e-publicacoes/programa-tipo-de-atuacao-em-saude-infantil-e-juvenil.aspx
(55) American College of Obstetricians and Gynecologists. Guidelines for Adolescent Health Care. 2nd edition. Washington, DC: American College of Obstetricians & Gynecologists; 2011.
(56) Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract. 2012;18(Suppl 1):1-78.
(57) McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948-67.
(58) Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-256.
(59) Back I de C, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FH, et al. I diretriz de prevenção da aterosclerose na infância e na adolescência. Arq Bras Cardiol. 2005;85(Suppl 6):4-36.
(60) Moráis A, Lama RA, Dalmau J. Hipercolesterolemia. Abordaje terapéutico. An Pediatr. 2009;70(5):488-96.
(61) Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi PR, et al. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;316(6):634-44.
(62) Wilkinson J, Bass C, Diem S, Gravley A, Harvey L, Maciosek M, et al. Preventive services for children and adolescents. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI); 2013.
(63) Moschonis G, Mavrogianni C, Karatzi K, Iatridi V, Chrousos GP, Lionis C, et al. Increased physical activity combined with more eating occasions is beneficial against dyslipidemias in children. The Healthy Growth Study. Eur J Nutr. 2013;52(3):1135-44.
(64) Organización Mundial de la Salud. Alimentación sana - Nota descriptiva Nº 394 [Internet]. WHO. 2015 [citado 15 de enero de 2017]. Disponible en: http://www.who.int/mediacentre/factsheets/fs394/es/
Esta revista ha conseguido la validación para ser 